prednisone induction - chloroquine
Phase 3Small molecule
prednisone induction - chloroquine is one of 3 small molecule programs targeting Splenomegaly. It is currently in Phase 3.
1
Indications
1
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Splenomegaly
#DrugCompanyPhaseTrials
1Ojjaara
GGlaxo Dba Glaxosmithkline
Approved
Aralen
SanofiPhase 3
prednisone induction - chloroquine
LLihir Medical Centre
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- LLihir Medical Centre